Impact of second-line and later cetuximab-containing therapy and KRAS genotypes in patients with metastatic colorectal cancer: a multicenter study in Japan
暂无分享,去创建一个
E. Tokunaga | E. Oki | Y. Kimura | M. Morita | Y. Maehara | H. Saeki | K. Ando | S. Ida | Hajime Otsu | H. Kawano | R. Kumashiro | M. Shimokawa | Y. Emi